Selected research
Industry Research
Colorectal Cancer Molecular Diagnostics Industry Research Report 2026
Market perspective
The global Colorectal Cancer Molecular Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Colorectal Cancer Molecular Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Colorectal Cancer Molecular Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Colorectal Cancer Molecular Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent and Daangene and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Colorectal Cancer Molecular Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Colorectal Cancer Molecular Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Colorectal Cancer Molecular Diagnostics Market by Company
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Colorectal Cancer Molecular Diagnostics Segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Colorectal Cancer Molecular Diagnostics Segment by Application
Hospital
Third-Party Testing Agency
Others
Colorectal Cancer Molecular Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colorectal Cancer Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colorectal Cancer Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colorectal Cancer Molecular Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
Applications
- Hospital
- Third-Party Testing Agency
- Others
Companies covered
- Roche Diagnostics
- Abbott
- Thermo Fisher
- Qiagen
- Illumina
- Biomerieux
- Bio-Rad
- Agilent
- Daangene
- Amoydx
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Colorectal Cancer Molecular Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Polymerase Chain Reaction PCR
- 2.2.3 Molecular Hybridization
- 2.2.4 Biochip
- 2.2.5 Others
- 2.3 Colorectal Cancer Molecular Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Third-Party Testing Agency
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
- 3.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2027-2032)
4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
- 4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2021-2032)
- 5.2 Global Colorectal Cancer Molecular Diagnostics Growth Trends by Region
- 5.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Colorectal Cancer Molecular Diagnostics Market Dynamics
- 5.3.1 Colorectal Cancer Molecular Diagnostics Industry Trends
- 5.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
- 5.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
- 5.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
- 6.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Colorectal Cancer Molecular Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Colorectal Cancer Molecular Diagnostics Head Office and Area Served
- 6.4 Global Colorectal Cancer Molecular Diagnostics Players, Product Type & Application
- 6.5 Global Colorectal Cancer Molecular Diagnostics Manufacturers Established Date
- 6.6 Global Colorectal Cancer Molecular Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 7.2 North America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 8.2 Europe Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 10.2 South America Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Colorectal Cancer Molecular Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche Diagnostics
- 12.1.1 Roche Diagnostics Company Information
- 12.1.2 Roche Diagnostics Business Overview
- 12.1.3 Roche Diagnostics Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.1.5 Roche Diagnostics Recent Developments
- 12.2 Abbott
- 12.2.1 Abbott Company Information
- 12.2.2 Abbott Business Overview
- 12.2.3 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.2.4 Abbott Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.2.5 Abbott Recent Developments
- 12.3 Thermo Fisher
- 12.3.1 Thermo Fisher Company Information
- 12.3.2 Thermo Fisher Business Overview
- 12.3.3 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.3.5 Thermo Fisher Recent Developments
- 12.4 Qiagen
- 12.4.1 Qiagen Company Information
- 12.4.2 Qiagen Business Overview
- 12.4.3 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.4.5 Qiagen Recent Developments
- 12.5 Illumina
- 12.5.1 Illumina Company Information
- 12.5.2 Illumina Business Overview
- 12.5.3 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.5.4 Illumina Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.5.5 Illumina Recent Developments
- 12.6 Biomerieux
- 12.6.1 Biomerieux Company Information
- 12.6.2 Biomerieux Business Overview
- 12.6.3 Biomerieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.6.5 Biomerieux Recent Developments
- 12.7 Bio-Rad
- 12.7.1 Bio-Rad Company Information
- 12.7.2 Bio-Rad Business Overview
- 12.7.3 Bio-Rad Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.7.5 Bio-Rad Recent Developments
- 12.8 Agilent
- 12.8.1 Agilent Company Information
- 12.8.2 Agilent Business Overview
- 12.8.3 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.8.4 Agilent Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.8.5 Agilent Recent Developments
- 12.9 Daangene
- 12.9.1 Daangene Company Information
- 12.9.2 Daangene Business Overview
- 12.9.3 Daangene Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.9.4 Daangene Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.9.5 Daangene Recent Developments
- 12.10 Amoydx
- 12.10.1 Amoydx Company Information
- 12.10.2 Amoydx Business Overview
- 12.10.3 Amoydx Revenue in Colorectal Cancer Molecular Diagnostics Business (2021-2026)
- 12.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Product Portfolio
- 12.10.5 Amoydx Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst